Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
participant satisfaction and client retention rates. As a key collaborator with business development, marketing and program innovation teams, this role will be critical to Chicago Booth’s mission To create
-
extensions, and agency-required re-budgeting. Research new avenues for funding and new grant opportunities. Supports department’s grant workshop/training initiatives for postdocs and graduate students
-
, Molecular Biology, Plant Biology. Experience: Training in Molecular and Plant Biology beyond the PhD. Significant publications on research in plants. Technical Knowledge or Skills: Knowledge of basic computer
-
of malignancies, blood disorders, and experimental therapies. Job Summary The Data Scientist will lead data science research efforts within breast cancer program in the Section of Hematology/Oncology in
-
/UChicago/benefits-guide/ We anticipate that one of the appointees from this search will also serve in the role of Medical Director for Pediatric Stem Cell and Cellular Therapy Program Service Line of the
-
and executing programs and workshops, and supporting program administration including reporting and analytics. This role will primarily support students who have an interest in finance careers including
-
Hospital, Highland Park Hospital, and Northwest Community Hospital. The Chief will oversee surgical quality, program development, and collaborative integration with structural heart, advanced heart failure
-
, Humanities, and Social Sciences (CSI), the Straetz International Research Scholars program, the IJRA Program with the University of Sussex, and the annual University of Chicago Undergraduate Research Symposium
-
for Academic Initiatives, is responsible for the strategic leadership, administration, and expansion of academic initiatives promoted by BFI beginning with the Master’s program in economics (MA Program). The
-
clinical research. Our research program is one of the largest gynecologic oncology programs in the Midwest, with an average of 18-22 therapeutic phase phase I-III trials open at all-times. We need a clinical